Cite
HARVARD Citation
Zelis, N. et al. (2014). Treatment with lenalidomide (Revlimid®), cyclophosphamide (Endoxan®) and prednisone (REP) in relapsed/refractory multiple myeloma patients: results of a single centre retrospective study. Acta clinica belgica. 69 (2), pp. 98-103. [Online].